BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 7.4% in October

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 79,800 shares, a decline of 7.4% from the September 30th total of 86,200 shares. Based on an average trading volume of 195,000 shares, the days-to-cover ratio is presently 0.4 days.

Insider Transactions at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. purchased 27,148 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Tuesday, September 17th. The stock was purchased at an average price of 15.93 per share, with a total value of 432,467.64. Following the completion of the acquisition, the insider now owns 20,565,579 shares of the company’s stock, valued at approximately 327,609,673.47. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last ninety days, insiders have acquired 99,630 shares of company stock valued at $1,585,113.

Institutional Trading of BlackRock Health Sciences Term Trust

Institutional investors and hedge funds have recently bought and sold shares of the company. Register Financial Advisors LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 5,365.6% in the 2nd quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after acquiring an additional 6,707 shares during the last quarter. Shaker Financial Services LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the second quarter worth $184,000. Comerica Bank lifted its position in shares of BlackRock Health Sciences Term Trust by 31.1% in the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after buying an additional 3,671 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust in the 1st quarter valued at about $285,000. Finally, Dakota Wealth Management grew its position in shares of BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after buying an additional 915 shares during the last quarter.

BlackRock Health Sciences Term Trust Price Performance

BMEZ stock traded up 0.13 during mid-day trading on Friday, hitting 15.56. 43,020 shares of the company were exchanged, compared to its average volume of 264,645. The firm has a fifty day simple moving average of 15.83 and a 200 day simple moving average of 15.48. BlackRock Health Sciences Term Trust has a twelve month low of 13.25 and a twelve month high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently declared a monthly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were paid a $0.176 dividend. The ex-dividend date of this dividend was Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a yield of 13.57%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.